NYSE ARCA | ETF
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 5.91% |
| SRRK | Scholar Rock Holding Corp | Healthcare | Biotechnology | 5.57% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.68% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.53% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.53% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 4.41% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 4.29% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 4.29% |
| XENE | Xenon Pharmaceuticals Inc | Healthcare | Biotechnology | 4.24% |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd | Healthcare | Biotechnology | 4.20% |
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 4.05% |
| 326030 | Sk Biopharmaceuticals Co Ltd | Healthcare | Biotechnology | 3.93% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 3.90% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 3.88% |
| SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.75% |
| AXNX | Axonics Modulation Technologies Inc | Healthcare | Medical Devices | 3.69% |
| LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 3.66% |
| EWTX | Edgewise Therapeutics Inc | Healthcare | Biotechnology | 3.43% |
| DYN | Dyne Therapeutics Inc | Healthcare | Biotechnology | 3.15% |
| HLUN-B | H Lundbeck A/S | Healthcare | Drug Manufacturers - Specialty & Generic | 3.03% |